Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells  by Horwitz, Marc S. et al.
Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and
this occurs independent of T cells
Marc S. Horwitz,a Alex Ilic, Cody Fine,b Enrique Rodriguez,b and Nora Sarvetnickb,*
aDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, BC V6T 123, Canada
bDepartment of Immunology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA
Received 10 February 2003; returned to author for revision 1 April 2003; accepted 29 May 2003
Abstract
The induction of autoimmunity by viruses has been hypothesized to occur by a number of mechanisms. Coxsackievirus B4 (CB4)
induces hyperglycemia in SJL mice resembling diabetes in humans. While virus is effectively cleared within 2 weeks, hyperglycemia does
not appear until about 8–12 weeks postinfection at a time when replicative virus is no longer detectable. In SJL mice, reinfection with CB4
enhanced the development of hyperglycemia. As predicted, the immune system responded more rapidly to the second infection and virus
was cleared more swiftly. However, while infiltrating T cells were found within the pancreas, depletion of the CD4 T cell population prior
to secondary infection or use of CD8 knock-out mice had no effect on the development of virus-mediated hyperglycemia. In conclusion,
enhanced hyperglycemia induced by CB4 occurs independent of the T cell response.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Insulin-dependent diabetes mellitus (IDDM) is charac-
terized by a destructive autoimmune response against the
pancreatic islets leading to the loss of insulin-producing 
cells and altered glucose utilization. In humans, viral infec-
tions and epidemics have often preceded clinical autoim-
mune disease. The most compelling evidence linking viral
infection to autoimmunity comes from investigations impli-
cating coxsackievirus as an etiological agent in IDDM.
Epidemiological studies have strongly implicated cox-
sackievirus infection as a frequent precedent in patients that
ultimately suffer from IDDM (Andreoletti et al., 1998; Che-
hadeh et al., 2000; Juhela et al., 2000; Nairn et al., 1999;
Sadeharju et al., 2001). In multiple studies, PCR analysis of
patients at the onset of type I diabetes detected coxsackievi-
ral RNA, whereas none was detected in healthy nondiabetic
individuals (Andreoletti et al., 1997; Clements et al., 1995;
Lonnrot et al., 2000a, 2000b). The frequently detected CB4
strain was isolated from patients with IDDM, passaged
several times through murine pancreatic  cells, and sub-
sequently found to induce a diabetes-like disease in suscep-
tible mice, SJL and CD1 (Webb et al., 1976; Yoon et al.,
1978). Approximately 25% of SJL mice develop hypergly-
cemia by 8–12 weeks after CB4 infection (Chatterjee et al.,
1985, 1988; Hartig and Webb, 1983; See and Tilles, 1995).
This diabetes-like syndrome was characterized by increases
in blood glucose, loss of pancreatic acinar tissue, and mild
insulitis. While the mechanism for disease induction has not
yet been determined, the generation of anti-islet antibodies
and autoreactive lymphocytes has implicated the adaptive
response in the development of disease in both mice (Chat-
terjee et al., 1992; Gerling et al., 1991; Hou et al., 1994) and
humans (Klemetti et al., 1999; Sarugeri et al., 2001; Varela-
Calvino et al., 2001). However, unlike other virus-induced
autoimmune models (McRae et al., 1995; Miller et al.,
1997), this “autoimmune” response does not amplify over
time, as the hyperglycemia does not progress to overt dia-
betes (Chatterjee et al., 1985, 1988; Hartig and Webb, 1983;
See and Tilles, 1995).
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Whereas destructive autoimmune diabetes is clearly as-
sociated with the development of autoreactive T cells, there
is no direct evidence that the initial  cell damage is actually
mediated by anti-islet-specific T cells. Indeed, in human
IDDM, most histopathological evidence points away from T
cells as the direct cause for  cell loss. Instead, disruption of
the  cell plasma membrane and invasion of the islets by
macrophages have been described to precede later stage
lymphocyte infiltration (Gepts, 1965; Hoet et al., 1987).
Insulitis, in human IDDM, is an elusive lesion and does not
have the strong association to diabetes as it does in the NOD
mouse and other animal models of IDDM (Cahill and Mc-
Devitt, 1981; Gepts and Int Veld, 1987; Gepts and Le-
compte, 1981). Therefore, although viral-mediated autoim-
mune diseases are approached by studying the regulation of
autoreactive T cells, these T cells may not be the initial
instigating factor and may instead be a secondary result of
tissue damage. In mouse models of diabetes, other immune
cell types, primarily those of the innate immune system,
have been implicated in the initiation of  cell dysfunction
and hyperglycemia (Flodstrom et al., 2002; See and Tilles,
1995). We hypothesized that the CB4-mediated clinical
hyperglycemia in SJL mice was initiated independent of T
cells. To test this hypothesis, we ascertained the require-
ment for T cells in disease development. Our results clearly
demonstrated the exacerbation of clinical hyperglycemia
following repeated infections without participation of the T
cell response. These studies suggest that CB4-mediated
diabetes does not require T cells and that exacerbation of
disease following reexposure to virus may reflect the acti-
vation of distinct immune and nonimmune mechanisms.
Results
Hyperglycemia in CB4-infected SJL mice
SJL mice were inoculated with 104 PFU of CB4, and
blood glucose (BG) was monitored from nonfasting mice
weekly. For as late as 4 weeks postinfection (p.i.), a
pronounced hypoglycemia resulted (less than 80 mg/dl).
Elevated nonfasting BG levels (200 mg/dl) were ob-
served in a proportion (23%, 14/60) of mice from 8 –12
weeks p.i. (Figs. 1A and B). BG levels were rarely
greater than 300 mg/dL (normal nonfasting blood glucose
values range from 80 –120 mg/dl). Uninfected SJL mice
did not demonstrate BG values greater than 200 mg/dl
(Fig. 1A). This clinical course was similar to published
reports, indicating an initial hypoglycemia followed by a
moderate hyperglycemia in a proportion of the mice, but
in a time course of over 1 year this did not progress to
overt IDDM (Chatterjee et al., 1985, 1988; Hartig and
Webb, 1983; See and Tilles, 1995). Histological exami-
nation of tissue following CB4 infection showed severe
pancreatitis as early as day 3 p.i. and peaking at day 7 p.i.
with necrosis and loss of exocrine tissue. Over time, the
lost exocrine tissue was replaced by fat tissue and little to
no regeneration of exocrine tissue was observed. As
expected, a significant immune cell infiltration was ob-
served as early as 3 days p.i. in the pancreas and was
much reduced by 28 days p.i. At 8 –12 weeks postinfec-
tion, few immune cells remained and these resided pre-
dominantly in the fat-replaced exocrine tissue. In the
endocrine tissue, some of the islets of Langerhans ap-
peared hypercellular, but, in general, the islets appeared
unaffected by the cytolytic effects of the virus. Immuno-
histochemical analysis indicated that T cells and macro-
phages did not constitute the increased cellularity of the
islets (data not shown (DNS)). Immunohistochemical
staining for the islet hormones, insulin, glucagon, and
somatostatin, did not reveal an overt loss of islet structure
or hormone content (Fig. 2, and DNS). Despite the hy-
Fig. 1. Incidence of hyperglycemia in SJL mice following CB4 infection.
(A) Two groups of SJL mice (n  33 and n  25) were infected with 104
PFU of CB4. One of the groups was reinfected 6 weeks after the first
infection with 104 PFU of CB4. Mice were monitored weekly for blood
glucose and mice with values over 200 mg/dl were considered hypergly-
cemic. Age-matched uninfected SJL mice (n  20) were also analyzed
alongside the infected mice and none of these mice developed BG values
over 200 mg/dl. The level of significance in hyperglycemia between single
and double infection is P  0.02. At week 10 postinfection, 48% of the
double-infected mice, 23% of the single-infected mice, and 0% of the
uninfected mice were considered hyperglycemic. (B, next page) In one
cohort study, 12 mice were monitored for BG values weekly following a
single infection of CB4. Each mouse is represented by a different color or
patterned line. (C, next page) In one cohort study of reinfection, 14 mice
were monitored for BG values weekly following a single infection and
through double infection with CB4. Mice undergoing only a single infec-
tion (n  7) are displayed in green. Mice undergoing both single and
double infections (n  7) are displayed in red. Different mice are repre-
sented by a different symbol. 10,000 PFUs of CB4 were injected i.p. on day
0 and day 42 (week 6). The mice were followed for 77 days (11 weeks).
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Fig. 2. Summary of histological analysis of pancreatic sections from single- and double-infected mice Representative sections of the pancreas from
CB4-infected SJL mice following both single and double infection. Infected SJL mice reveal loss of exocrine tissue, replacement with fat tissue, hypercellular
islets of langerhans, and generalized immune infiltration. No obvious loss in islet cell integrity or function was observed.  cell function was confirmed by
immunohistochemistry using antibody to insulin (400) present as brown staining. Slightly larger numbers of immune cells are visible in double-infected
mice than in single infected mice. Mice were sacrificed at 2 weeks postsecond infection (or 8 weeks postfirst infection).
perglycemia, pancreatitis, and pancreatic atrophy, no
marked loss of  cells was observed.
Reinfection with CB4 leads to the enhancement of clinical
disease
The immune response to pathogens and to self is shaped
by an individual’s infection history. Both infections and
immunizations establish a protective memory immune re-
sponse through activation of naive lymphocytes as well as
reactivation of memory T and B cell responses to prior
insults (Hafler et al., 1987; Selin et al., 1998; Walzl et al.,
2000; Welsh et al., 2000). As a consequence of activation of
a strong antiviral T cell memory response following infec-
tion, non-viral-specific memory T cells are also activated
(Selin et al., 1998; Tough et al., 1996). While a single
infection may not necessarily result in destructive autoim-
munity, it could expand a significant subpopulation of self-
reactive components within the host. Exposure to sequential
infections with the same or a related pathogen is a common
occurrence and could trigger destructive autoimmunity by
reactivation of the self-reactive memory T cells. In mice,
secondary exposure to myocarditic variants of coxsackievi-
ruses resulted in exacerbation of myocarditis (Beck et al.,
1990). In an effort to determine if restimulation of the CB4
immune response could enhance disease, SJL mice were
infected with CB4, allowed to rest for 6 weeks, and rein-
oculated with CB4. A greater proportion of SJL mice rein-
fected with CB4 had elevated BG levels (200 mg/dL)
(48%, 16/33) as compared to single infected (23%, 14/60)
(P  0.02) or uninfected age-matched mice (0%, 0/25)
(Figs. 1A and C). Histological analysis at 2–4 weeks post-
second infection revealed that reinfected SJL mice had
increased numbers of infiltrating immune cells in the pan-
creas as compared to single-infected animals, yet this num-
ber was low relative to spontaneously diabetic mice. The
overall insulitis index of the three groups of mice remained
low (double infected, 5%; single infected, 1%; unin-
fected, 0%). More importantly, loss of islet  cells or their
insulin production was not observed (Fig. 2). CB4 infection
induces atrophy and necrosis of the pancreatic exocrine
tissue, complicating the analysis of cellular immune mark-
ers by immunohistochemistry. Nonetheless, following sec-
ond infection, while there was an observed increase in
macrophages and T cells in the pancreas compared to the
single infected mouse, very few of these cells were found
within the islets (DNS).
As expected, immunocytometric analysis of peripheral
blood lymphocytes from the sera of mice before and at
weekly intervals postinfection for several immune cell
markers demonstrated activation and expansion of all the
major cellular immune components (T and B cells, macro-
phages, and natural killer (NK) cells (Table 1)). Likewise,
following the second infection, T and B cells responded
earlier to the second challenge as was measured by the
activation/memory markers, CD25 and CD44.
We assessed the functional memory response by study-
ing viral clearance after the primary and secondary infec-
tions. Viral replication following first and second infection
was assayed by standard plaque assay. After the initial
infection, the majority of virus was found in the pancreas
with the peak of replication at 2–3 days p.i. Replicative
virus was no longer recoverable (102/tissue) from any
Table 1
FACS analysis of immune effector cells following viral challenge
Immune cell activation following CB4 infection
Preinfection 1 week
p.i.a
2 week
p.i.a
1 week
P2ndIa
2 week
P2ndIa
T cells
CD4, CD25 1 15.9  6.5 7.6  5.3 20.9  5.2 5.9  2.1
CD4, CD44hi 9.3  3.4 32.8  9.8 12.9  5.5 31.7  6.8 13.1  3.8
CD8, CD25 1 18.9  5.9 1.6  0.5 26.3  5.9 8.0  4.3
CD8, CD44hi 9.0  3.3 41.5  10.3 25.9  5.0 38.0  7.9 22.0  4.4
B cells
CD19, CD25 1 16.6  8.0 43.2  12.0 67.4  11.5 87.2  3.5
Macrophages
F4/80 5.0  3.1 15.4  8.1 6.2  2.3 6.7  2.1 4.5  1.9
NK cells
LFA-1, CD2 23.7  2.8 42.5 5.1 ND ND ND
n 8 8 8 7 6
Note. Peripheral blood lymphocytes were analyzed for immune cell effectors with immunofluorescent antibodies as described under Materials and methods.
Mice were bled at weekly intervals and followed over the course of the double-infection protocol. Activation of T cells was measured by increases in CD25
and CD44 surface expression on CD4 and CD8 cells, while B cell activation was measured by increases in CD25 on the surface of CD19 cells. Activated
macrophages were measured by changes in F4/80 on their surface. Activated NK cells were measured by increases in surface CD2 and LFA-1. The changes
displayed in cell population numbers and activation are consistent with a memory response to a virus following second infection. a p.i. postinfection; P2ndI
 postsecond infection.
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tissue by day 28. After reinfection, the pancreas had signif-
icantly less virus (about 4–5 logs, P value  0.001) 3 days
p.i. compared to the initial infection (Fig. 3). Also, viral
replication peaked in the pancreas at day 3 p.i. and was no
longer recovered by day 14 p.i., demonstrating accelerated
clearance. These results are consistent with a standard naive
and memory-immune response to viral infection.
Pancreatic infection may lead to subtle changes in islet
function. Although overt diabetes was not observed and
hyperglycemia was intermittent, we asked whether virus
infection could alter glucose management. To test whether
 cell function was altered by CB4 infection, mice were
subjected to a glucose tolerance analysis. While no signif-
icant differences were observed in the ability of the unin-
fected (n 9), single- (n 13), or double-(n 13) infected
mice to handle glucose, when challenged with 2 g/kg fol-
lowing a 24-h fast (DNS), significantly lower glycemic
levels were observed in double-infected mice prior to the
test (following the 24-h fast or, in other words, the fasting
BG value) and at 1 h postglucose administration (P value
 0.001 and 0.005, respectively). This indicated that the
mice have an altered glucose homeostasis that is reflected in
their elevated glycemic nonfasting blood glucose levels.
Taken together, these results support the concept that re-
peated viral exposure leads to an increased frequency of hy-
perglycemia. Differences following a second infection with
CB4 included an increased level, frequency, and kinetics of an
altered glucose homeostasis. The low incidence of insulitis
suggests that immune infiltration of the pancreas does not
participate significantly in the observed hyperglycemia.
Fig. 3. Viral titers following CB4 single and double infections. SJL mice were infected with CB4 and sacrificed at 3, 7, 21, and 28 days postinfection.
Additionally, SJL mice previously infected with CB4 were reinfected with CB4 at 6 weeks PI and sacrificed at 3, 7, 21, and 28 days postsecond infection.
Organs were harvested and assayed from eight mice per time point for virus recovery by standard plaque assay. The viral titer is presented in log10 PFU/g
of tissue and standard deviations were measured in brackets. Viral titers from the pancreas (A) and spleen (B) are presented and compared between single-
and double-infected mice. The minimum level of detection is 2.5 log10 PFU/g of tissue and day 21 spleen and day 28 pancreas and spleen were below this
level. Double-infected mice had significantly less virus at day 3 p.i. than single-infected mice in both the pancreas and the spleen (***p  0.001).
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Role of the T cell response
To determine if increases in the specificity of the auto-
reactive T cell response following infection could be asso-
ciated with disease progression, proliferative lymphocyte
responses were measured and compared from splenocytes
removed before and following the first and second infec-
tions. Changes in the strength and specificity of the response
have previously been associated with changes in disease
pathology (Chatterjee et al., 1992; Gerling et al., 1991; Hou
et al., 1994; Klemetti et al., 1999; Sarugeri et al., 2001;
Varela-Calvino et al., 2001). For autoimmune diabetes,
GAD65 and HSP60 have both been demonstrated to be
targets of the anti-islet lymphocytic response (Kaufman et
al., 1992, 1993). To test the autoreactive response, prolif-
erative lymphocyte responses were measured and compared
from splenocytes removed before and 1 week following the
first and second infections. While strong proliferative re-
sponses were exhibited from splenocytes to GAD65 and
HSP60 from SJL mice, no significant differences in the
proliferative response to either was observed following sin-
gle or double infection (n  7) (Fig. 4). Therefore, the
development of hyperglycemia did not correspond with
increased responses to islet autoantigens. While SJL mice
showed no increase in response to islet autoantigens, they
may be prone to other autoreactive T cell specificities. To
address this possibility, the V T cell receptor (TCR) rep-
ertoire was analyzed. FACS analysis to a panel of antibodies
specific for the known V TCRs was performed on spleno-
cytes taken before and after first or second infection. No
obvious changes to the V TCR repertoire were observed in
either the CD4 or the CD8 T cell compartment following
single or double infection in SJL mice (DNS). Enhancement
of disease could not be associated with any major shift in
the V TCR repertoire. Therefore, changes in the TCR
diversity and the antigen specificity of the T cell response
were not associated with development of hyperglycemia
following CB4 infection.
To directly establish whether CD4 T cells are required
for enhancement of hyperglycemia, mice were depleted of
CD4 cells by antibody and rechallenged with CB4. SJL
mice were first given a single dose of CB4 and depleted of
CD4 cells 5 weeks postinfection with a monoclonal anti-
body specific for CD4. To assess depletion in the CD4 T
cell compartment, FACS analysis was performed on blood
from depleted mice prior to reinfection. Greater than 90% of
the CD4 T cell compartment were depleted and mice were
rechallenged with CB4. Blood glucose was monitored
weekly to measure increases in hyperglycemia. Interest-
ingly, the enhancement of hyperglycemia observed follow-
ing second infection was still observed despite the absence
of most CD4 T cells (n  20) (Fig. 5). Additionally, we
analyzed the CD4 T cell compartment 2 weeks postsecond-
ary infection and found that it remained CD4 depleted.
Fig. 4. Proliferative response of splenocytes from CB4-infected SJL mice. Three groups of SJL mice were examined for T cell proliferative responses:
uninfected SJL mice (n  4), single-infected SJL mice given a sham-infection at 6 weeks p.i. and tested 8 weeks after infection (n  6), and double-infected
SJL mice given their second infection at 6 weeks postfirst infection and tested 8 weeks postfirst infection (n  6). Mice were sacrificed and splenocytes were
harvested and assayed for proliferative responses to GAD65 and HSP60. The data from two experiments were pooled and presented as stimulation index (SI)
 SEM. No significant increases in SI were observed across the three groups of mice. Background in all experiments was between 500 and 2500 cpm.
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Furthermore, CD4 cells were not observed in the pancreas
by immunohistochemical analysis of pancreatic sections
from mice following depletion and reinfection (DNS). Al-
though the percentage of mice developing hyperglycemia is
lower in these experiments, it is equivalent to the level of
enhancement of mice double infected and greater than mice
given a single infection over the same experimental time
course. Therefore, our results show that the enhancement in
hyperglycemia exhibited following double infection of CB4
does not require CD4 T cells.
To determine whether hyperglycemia develops indepen-
dent of CD8 T cells, CD8 knock-out mice (Koh et al.,
1992) were backcrossed onto the SJL MHC background (12
generations) and infected with CB4 in both the single- and
the double-infection models. Again, no difference in hyper-
glycemia was observed between SJL and SJL CD8 KO mice
following either single or double infection (n 26) over the
same experimental time course. Hyperglycemia was clearly
enhanced following rechallenge with CB4 in both groups
(Fig. 5). These results demonstrate that CD8 T cells are
also not required for the development of hyperglycemia in
these mice.
Discussion
Our work demonstrates that reexposure to CB4 increases
the frequency and kinetics of onset of hyperglycemia. In-
deed, the heightened level of disease was characteristic of a
typical memory lymphocytic response with increased levels
of infiltrating immune cells observed in the pancreas fol-
lowing reexposure. However, neither CD4 or CD8 T
cells were required in the enhancement of hyperglycemia.
Unexpectedly, there was no evidence demonstrating any
changes to the T cell compartment that could be associated
with disease development. Therefore, we conclude that the
hyperglycemia mediated by coxsackievirus occurs indepen-
dent of the T cell response.
Certainly, one cannot rule out the possibility that the
presence of one T cell compartment was enough to com-
pensate and induce hyperglycemia since mice were not
tested that simultaneously lacked both T cell compartments.
However, when both CD4 and CD8 T cells are absent, as is
the case with the scid mouse model (Horwitz et al., 1999),
virus is not cleared from the mouse and a majority of mice
succumb to infection prior to 8 weeks p.i., at which time the
Fig. 5. Lack of CD4 or CD8 T cells does not affect the induction of hyperglycemia by CB4. SJL mice (n  20) infected 5 weeks prior with CB4 were
depleted of CD4 cells with a CD4-specific monoclonal antibody and reinfected with CB4 at 6 weeks p.i. Additionally, CD8 KO mice (n  26) bred onto
the SJL background (12 generations) were given the double-infection protocol and monitored for the development of hyperglycemia. Mice were monitored
weekly for blood glucose and mice with values over 200 mg/dl were considered hyperglycemic. Six week p.i. single-infected SJL mice (n  8) were
reinfected and analyzed alongside the infected depleted mice. At week 10 postprimary infection (or 4 weeks postsecondary infection), 30% of the
double-infected CD8ko mice, 25% of the double-infected CD4-depleted mice, 25% of the double-infected (not depleted) mice, and 12.5% of the single
infected mice were considered hyperglycemic.
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hyperglycemia is observed. More importantly, the lack of an
obvious presence of either CD4 or CD8 T cells within
the pancreas at disease onset, compared to other murine
models, strongly supports the conclusion that disease induc-
tion involves a T cell independent mechanism. The SJL
mice exhibited only mild hyperglycemia following infection
and their disease pathology (both BG and insulitis) was not
comparable to other mouse models. However, the CB4-
infected SJL mouse may more accurately reflect the initial
early events in human IDDM (Gepts, 1965; Gepts and
Lecompte, 1981; Hoet et al., 1987). Furthermore, the hy-
perglycemia observed in the CB4-infected SJL mice never
progresses to overt diabetes (Chatterjee et al., 1985, 1988;
Hartig and Webb, 1983; See and Tilles, 1995), implying that
the mechanism cannot self-perpetuate and progress as ob-
served in most autoimmune diseases. The induction and
enhancement of hyperglycemia in CB4-infected SJL mice
are therefore most likely due to mechanisms independent of
the adaptive immune system.
The lack of dependence on T cells in the development of
CB4-mediated hyperglycemia evokes a number of alterna-
tive possibilities both immune and nonimmune mediated.
Changes in B cells and their antibodies representative of
non-T cell adaptive responses could mechanistically direct
the observed change in glucose homeostasis. Autoantibod-
ies could interfere with the normal function of insulin or the
production and delivery of insulin to the blood system
without necessarily harming the  cell. Following a second
exposure to virus, memory B cells would respond to amplify
and strengthen the antibody response, which would serve to
enhance disease. Unfortunately, CB4 infection of B cell
knock-out mice on the SJL background resulted in death
within 1 week p.i. (DNS). The production of anti-islet cell
antibodies has been well documented to follow coxsackievi-
ral infections of both mouse (Gerling et al., 1988; See and
Tilles, 1995) and man (Roivainen et al., 1998; Vreugdenhil
et al., 1999), including antibody specific for insulin and
GAD. Increased autoantibody responses could alter the ef-
ficient function of glucose homeostasis following reinfec-
tion with CB4 and is currently under study. However, the
fact that CD4 depletion did not ameliorate disease suggests
that the autoantibodies are generated independent of CD4 T
cells and are, most likely, of low affinity. Additionally,
while prior work demonstrating increased myocarditis fol-
lowing secondary infection with CBV (Beck et al., 1990)
was initially thought to be due to cell-mediated immune
responses, more recent work strongly suggests a mechanism
of antibody enhancement of infectivity (AEI) (Girn et al.,
2002). Rather than being neutralizing, these low-affinity
antibodies could aid the virus in spread to hard to reach
tissues such as the islets and increase the degree of replica-
tion and subsequent pathology.
Alternatively, the innate response could drive the devel-
opment of disease. Following reexposure to a pancreatropic
virus, activated effector cells of the innate response could
act to alter glucose homeostasis directly by their own action
or indirectly by the cytokines that they elicit. It has been
recently suggested that a  cell’s own immune defenses are
important to its survival and the establishment of suscepti-
bility to the innate response (Flodstrom et al., 2002). NK
cells have been implicated as effectors that recognize CB4-
infected  cells and induce cell death (Flodstrom et al.,
2002). Herein, we demonstrated increased activation of both
macrophages and NK cells that accompanied reexposure to
CB4 and the development of hyperglycemia. Previous work
clearly demonstrated a role for interferon--stimulated mac-
rophages in the lysis of CB4-infected islet cells (See and
Tilles, 1995). Additionally, multiple cytokines have been
shown to alter islet cell function, resulting in a reduction in
insulin secretion. Interleukin-1, interferon- and tumor
necrosis factor- have been shown to act individually and in
combination to detrimentally effect islet  cell function and
integrity (Arnush et al., 1998; Campbell et al., 1988; Man-
drup-Poulsen, 1990, 1996; Wogensen et al., 1992).
The potential of nonimmune mechanisms of disease in-
duction may well rely on the ability of coxsackievirus to
persist in the mouse long past acute infection (as great as 1
year p.i.). This has been observed by multiple laboratories
by RT-PCR (Andreoletti et al., 1997; Berger et al., 1998;
Adachi, 1996 #826; Tam and Messner, 1999). Interestingly,
replicative virus has not been recovered from any tissue past
21 days p.i. The expression of virus or viral gene products
could influence the expression of host genes and affect the
balance and responsiveness of the endocrine system. There
are many examples of alterations in host gene expression
due to the presence of persistent virus (Lyles, 2000). For
example, LCMV has been shown to reduce the expression
of growth hormone in mice during persistent infection of the
endocrine tissue of the pituitary gland (Bureau et al., 2001).
Alternatively, persistence of CB4 within  cells could alter
their ability to respond to changes in glucose homeostasis.
In fact, CB4 has been implicated in alterations in expression
of GAD in pancreatic islets (Gerling et al., 1988; Hou et al.,
1993); however it is unclear whether GAD expression plays
a direct role in glucose homeostasis (Kash et al., 1999;
Yoon et al., 1999). Additionally, rechallenge with CB4 may
serve to spread CB4 infection to additional  cells, further
reducing insulin responsiveness.
CB4 infection may serve to reduce the function of other
cells involved in glucose homeostasis that are indeed sepa-
rate from the  cells of the islets of langerhans. Many cells
are involved in maintaining glucose homeostasis besides the
insulin-producing  cells and many of these cells are sus-
ceptible to CB4 infection. For instance, the glucagon-pro-
ducing  cells of the islets of langerhans, the amylase-
producing acinar cells of the pancreas, the glycogen storage
cells of the liver, and the insulin responsive cells of the
muscle and fat tissues are all involved in maintaining the
glucose balance. CB4 has been shown to specifically infect
and destroy many of these cells types following acute in-
fection (Loria et al., 1974). While the loss of acinar cells and
replacement with adipose tissue is observed following
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nearly all CBV infections, loss of cardiac muscle, liver, and
pancreatic  cells has also been reported (Campbell et al.,
1978; Chatterjee et al., 1989; Lansdown and Coid, 1974).
In conclusion, CB4-mediated hyperglycemia develops
independent of the T cell response, suggesting that clinical
IDDM could similarly develop initially independent of the
adaptive immune response. Viral-induced hyperglycemia
could represent an initial step in the development of IDDM
that subsequently progresses into autoimmunity. Therefore,
the development of better preventative therapies for IDDM
based on the rapid clearance of virus and promotion of
cellular repair may have greater efficacy than immunother-
apeutic approaches.
Materials and methods
Mice and virus
SJL mice were obtained from the rodent breeding colony
at The Scripps Research Institute (La Jolla, CA). The CD8
knock-out (CD8/) mice generated by Tak Mak (Koh et
al., 1992) were obtained from him and backcrossed eight
generations to SJL mice. Virus stocks of Coxsackie virus
group B type 4 Edwards strain 2 (CB4 strain E2) were
obtained from Charles Gauntt (Univ. of Texas-San Antonio)
and were derived from stocks obtained from Roger Loria
(Medical College of VA, VCU) (Webb et al., 1976). CB4
was originally isolated from patients with IDDM, passaged
through murine pancreatic  cells, and subsequently found
to induce a diabetes-like disease in mice (See and Tilles,
1995; Webb et al., 1976; Yoon et al., 1978). Virus stocks of
CB4 strain E2 were prepared and titered as previously
described (Horwitz et al., 1999). Viral titers were deter-
mined on HeLa cell monolayers using a standard plaque
assay technique. Virus was plaque assayed in tissue from
individual organs, aseptically weighed, and homogenized in
diluent. Mice were infected after 6 weeks of age intraperi-
toneally (i.p.) with 104 PFU of CB4. Secondary infections
consisted of 106 PFU of CB4 given i.p. at 6 weeks postin-
fection. Blood glucose was measured in tail vein or eye
bleeds from nonfasting mice at various times from 1 to 28
days postinfection or posttreatment on a standard glucom-
eter with a range of 20–400 mg/dL. Mice were considered
hyperglycemic when two or more consecutive readings (24
h apart) were greater than 200 mg/dL. Statistical analysis
using the Fisher’s exact test was performed on paired
groups.
Immunohistochemical staining
Organs were removed and placed in 10% formaldehyde
and then processed for paraffin sectioning. Alternatively,
organs were snap frozen in OCT on dry ice. Immunohisto-
chemistry was performed on 4-m-thick paraffin sections
for insulin staining or 7-m cryocut sections for the other
antibodies that were prepared and blocked with avidin and
biotin (Vector Laboratories, Burlingame, CA). The primary
antibodies were to insulin (Dako, Carpinteria, CA), F4/80
(Serotec, Washington, DC), CD4, and CD8 (PharMingen,
La Jolla, CA) and the secondary antibody was a biotinylated
anti-guinea pig IgG (for insulin staining) or anti-rat IgG (for
the other antibodies) used in conjunction with the Vec-
tastain ABC (peroxidase) kits (Vector Laboratories, Carpin-
teria, CA). Staining was detected using diaminobenzidine as
a chromagen. Sections were counterstained in Mayer’s he-
matoxylin (Sigma, St. Louis, MO) and mounted in Per-
mount (Fisher, Pittsburgh, PA). Quantitation of the degree
of pancreatic insulitis was evaluated using both anti-insulin-
stained and multiple hematoxylin and eosin stained pancre-
atic sections from infected and uninfected, age-matched SJL
mice, scored for peri-insulitis and insulitis. Statistical anal-
ysis using 2 tests were done on paired groups.
FACS analysis
Peripheral blood was obtained from mice before, and 1
and 2 weeks postprimary infection, and before, and 1 and 2
weeks postsecondary infection. Erythrocytes were lysed by
NH4Cl treatment and lymphocytes were incubated with
fluorescein isothiocyanate (FITC)-labeled antibody to CD8
and Cy-chrome-labeled CD4 (BDB PharMingen, La Jolla,
CA), and phycoerythrin(PE)-labeled antibody to either
CD25 or CD44 (BDB PharMingen). Additionally, cells
were labeled with antibody to B220 (Cy-chrome), and
CD25 (PE) and CD19 (FITC) or Mac1 (FITC) and F4/80
(PE) or LFA-1 (PerCP) and CD2 (PE) (BDB PharMingen).
Cells were fixed in 1% paraformaldehyde and analyzed with
a Becton–Dickinson FACS. A minimum of 200,000 events
was analyzed for each sample. For the TCR repertoire
analysis, FITC-labeled monoclonal antibodies for V2,
V3, V4, V6, V7, V14, V17 (BDB PharMingen)
were used in conjunction with PE-labeled monoclonal an-
tibody for either CD4 or CD8 (BDB PharMingen). As a
control, FITC-labeled mAb for V8.1/8.2 and V8.3 were
used, as these TCRs are not available in the SJL mouse.
T cell proliferation assays
For T cell proliferation studies (assays were similar to
previous studies; Horwitz et al., 1998), mice were sacrificed
at various times postinfection. Spleens were removed and
cultured in triplicate on 96-well plates (5  105/well) in
HL-1 media with antigen including GAD65 (recombinant
protein generated from baculovirus constructs; Tisch et al.,
1993), GAD-derived peptide (GAD65(255–269) ARYKM-
FPEVKEKGMAA), and HSP60. Whole proteins were
added at 20 g/ml and peptides were added at 7M. Cul-
tures were incubated for 3 days at 37°C and pulsed for 8 h
before harvest with 1 Ci 3H-thymidine. Incorporation of
3H-thymidine was measured using a liquid scintillation
counter. The stimulation index was calculated for each
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mouse splenocyte sample as compared to control wells
lacking additional antigen.
CD4 T cell depletion
CD4-specific antibody was produced from hybridoma,
YTS 191.1.2, and was a gift from Joanna Davies. Mice were
depleted of CD4 T cells by three i.p. injections (a total of 1
mg of antibody) of this T cell-depleting rat monoclonal
antibody over the course of 1 week. The first injection was
given 5 weeks following the initial dose of CB4 and 1 week
prior to the second dose of virus. In this manner, CD4 T
cells were absent for the enhancement of disease. Loss of
CD4 T cells was confirmed by FACS analysis.
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